Drug Shortage Report for TEVA-BICALUTAMIDE

Last updated on 2018-03-13 History
Report ID 29450
Drug Identification Number 02270226
Brand name TEVA-BICALUTAMIDE
Common or Proper name BICALUTAMIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BICALUTAMIDE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code L02BB
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-16
Estimated end date 2018-01-15
Actual end date 2018-03-05
Shortage status Resolved
Updated date 2018-03-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-03-13 French Compare
v4 2018-03-13 English Compare
v3 2017-11-17 English Compare
v2 2017-11-16 French Compare
v1 2017-11-16 English Compare